CPHA Canvax

"A review and summarization of the article Efficacy and safety of mRNA-1273 SARS-CoV-2 vaccine, an article in which “the authors report interim findings of a phase-3 randomized, stratified, observer-blinded placebo-controlled trial to evaluate the efficacy and safety of the Moderna mRNA-1273 COVID19 vaccine.” The review ends with comments on the limitations of the study and outlines additional studies needed to address said limitations and other gaps in understanding surrounding the mRNA-1273 SARS-CoV-2 vaccine." - Review of “Efficacy and safety of mRNA-1273 SARS-CoV-2 vaccine”

Rating See Comments Ratings

Category:

Vaccine Safety and Development,Vaccine Safety,Research and Development,Sub Topics: Vaccine Safety and Development,Vaccine Effectiveness and Efficacy,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and Development
Vaccine Safety
Research and Development
Sub Topics: Vaccine Safety and Development
Vaccine Effectiveness and Efficacy
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.